The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...
During an asthma check-up at Brigham and Women's Hospital in Boston, Joel Rubinstein gets a surprising pitch — for the planet, as well as his health. His pulmonologist, Dr. Miguel Divo, explains that ...
Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...
People with asthma know how important inhalers are, but they are also a source of planet-warming pollution. A new study looks at that impact and what can be done. Millions of people depend on asthma ...
“Since I’ve been vice president, we have capped the cost of prescription medication for seniors at $2,000 a year.” The development of green inhalers jeopardizes those gains. Drug companies will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results